Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase ...
Q1 2026
May 15, 2026
FY 2025
Dec 31, 2025
Q4 2025
Q3 2025
Nov 14, 2025
Q1 2025
May 9, 2025
